Literature DB >> 18198214

Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor.

Tetsuya Mizuno1, Guiqin Zhang, Hideyuki Takeuchi, Jun Kawanokuchi, Jinyan Wang, Yoshifumi Sonobe, Shijie Jin, Naoki Takada, Yukio Komatsu, Akio Suzumura.   

Abstract

Interferon-gamma (IFN-gamma) is a proinflammatory cytokine that plays a pivotal role in pathology of diseases in the central nervous system (CNS), such as multiple sclerosis. However, the direct effect of IFN-gamma on neuronal cells has yet to be elucidated. We show here that IFN-gamma directly induces neuronal dysfunction, which appears as dendritic bead formation in mouse cortical neurons and enhances glutamate neurotoxicity mediated via alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic (AMPA) receptors but not N-methyl-D-aspartate receptors. In the CNS, IFN-gamma receptor forms a unique, neuron-specific, calcium-permeable receptor complex with AMPA receptor subunit GluR1. Through this receptor complex, IFN-gamma phosphorylates GluR1 at serine 845 position by JAK1.2/STAT1 pathway, increases Ca(2+) influx and following nitric oxide production, and subsequently decreases ATP production, leading to the dendritic bead formation. These findings provide novel mechanisms of neuronal excitotoxicity, which may occur in both inflammatory and neurodegenerative diseases in the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198214     DOI: 10.1096/fj.07-099499

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  57 in total

1.  Plasticity of the myelination genomic fabric.

Authors:  Sanda Iacobas; Neil M Thomas; Dumitru A Iacobas
Journal:  Mol Genet Genomics       Date:  2012-01-13       Impact factor: 3.291

2.  On the origin of the triplet puzzle of homologies in receptor heteromers: immunoglobulin triplets in different types of receptors.

Authors:  Alexander O Tarakanov; Kjell G Fuxe; Dasiel O Borroto-Escuela
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

3.  Homeostatic interferon expression in neurons is sufficient for early control of viral infection.

Authors:  Sarah E Cavanaugh; Alicia M Holmgren; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2014-12-16       Impact factor: 3.478

4.  Possible role of receptor heteromers in multiple sclerosis.

Authors:  A O Tarakanov; K G Fuxe; L F Agnati; L B Goncharova
Journal:  J Neural Transm (Vienna)       Date:  2009-02-20       Impact factor: 3.575

5.  Triplet puzzle: homologies of receptor heteromers.

Authors:  Alexander O Tarakanov; Kjell G Fuxe
Journal:  J Mol Neurosci       Date:  2009-12-04       Impact factor: 3.444

6.  Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function.

Authors:  G Nagesh Babu; Alok Kumar; Ram Lakhan Singh
Journal:  Neurotox Res       Date:  2010-03-09       Impact factor: 3.911

7.  Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Authors:  Yoshifumi Sonobe; Hideyuki Takeuchi; Kunio Kataoka; Hua Li; Shijie Jin; Maya Mimuro; Yoshio Hashizume; Yasuteru Sano; Takashi Kanda; Tetsuya Mizuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

8.  C3aR inhibition reduces neurodegeneration in experimental lupus.

Authors:  A Jacob; L Bao; J Brorson; R J Quigg; J J Alexander
Journal:  Lupus       Date:  2009-11-09       Impact factor: 2.911

Review 9.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

Review 10.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.